Archive: October 09 2019
Find relevant news articles from other European projects, below:
Browse our carefully curated library of the latest news and developments in all areas of immunotherapy here:
Phase III CASSIOPEIA Impacts Treatment Decisions in Patients With Multiple Myelo...
Sonneveld says that not only high-risk patients but all those who are transplant-eligible and newly diagnosed may potentially have a new standard of care in the future.